Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

AGED Diagnostics Epigenetic Modifications of Liver Disease Assessment

NCT06348563 is registered in ClinicalTrials.gov with Active Genomes Expressed Diagnostics, Corp as lead sponsor.

NCT NCT06348563
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT06348563 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
AGED Diagnostics Epigenetic Modifications of Liver Disease Assessment
Lead sponsor
Active Genomes Expressed Diagnostics, Corp
Phase
Phase 1
Overall status
Unknown status
Start date
May 15, 2024
Completion date
September 15, 2025
Enrollment
400 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

healthy, nafld, nash with fibrosis